Lipocine
Utility Patent Applications

Last updated:

List of all Lipocine patents 41 in total

Status Patent
Application
Utility: COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS External link
Filling date: 8 Sep 2025 Issue date: 25 Nov 2021
Application
Utility: Steroidal Compositions External link
Filling date: 8 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 10 Jun 2021
Application
Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 15 Apr 2021
Application
Utility: Steroidal Compositions External link
Filling date: 8 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS External link
Filling date: 8 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: Steroidal Compositions External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: Fixed Dose Oral Testosterone Undecanoate Compositions and Use Thereof External link
Filling date: 8 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions External link
Filling date: 8 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: Liver Disease External link
Filling date: 8 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: Liver Disease External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: STEROIDAL COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS External link
Filling date: 8 Sep 2025 Issue date: 10 Sep 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 30 Jul 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: ORAL TESTOSTERONE TRIDECANOATE THERAPY External link
Filling date: 8 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: COMPOSITION AND METHOD FOR ORAL DELIVERY OF ANDROGEN PRODRUGS External link
Filling date: 8 Sep 2025 Issue date: 16 Jul 2020
Application
Utility: TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 18 Jun 2020
Application
Utility: PHARMACEUTICAL COMPOSITION AND METHODS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: LIVER DISEASE External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Application
Utility: Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS External link
Filling date: 8 Sep 2025 Issue date: 13 Feb 2020
Application
Utility: LIVER DISEASE External link
Filling date: 8 Sep 2025 Issue date: 23 Jan 2020
Application
Utility: (17- )-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use External link
Filling date: 8 Sep 2025 Issue date: 26 Dec 2019
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS External link
Filling date: 8 Sep 2025 Issue date: 5 Dec 2019
Application
Utility: (17- )-3-OXOANDROST-4-EN-17YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE External link
Filling date: 8 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS External link
Filling date: 8 Sep 2025 Issue date: 21 Nov 2019
Application
Utility: METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODS External link
Filling date: 8 Sep 2025 Issue date: 24 Oct 2019
Application
Utility: 17-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods External link
Filling date: 8 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS External link
Filling date: 8 Sep 2025 Issue date: 12 Sep 2019
Application
Utility: PHARMACEUTICAL COMPOSITION AND METHODS External link
Filling date: 8 Sep 2025 Issue date: 5 Sep 2019
Application
Utility: ORAL TESTOSTERONE UNDECANOATE THERAPY External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019
Application
Utility: LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERY External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019

Showing 1 to 41 of 41 patents.